BR0002872A - Solução aquosa para nutrição parenteral. - Google Patents

Solução aquosa para nutrição parenteral.

Info

Publication number
BR0002872A
BR0002872A BR0002872-0A BR0002872A BR0002872A BR 0002872 A BR0002872 A BR 0002872A BR 0002872 A BR0002872 A BR 0002872A BR 0002872 A BR0002872 A BR 0002872A
Authority
BR
Brazil
Prior art keywords
mmoles
aqueous solution
acid
parenteral nutrition
tyrosine
Prior art date
Application number
BR0002872-0A
Other languages
English (en)
Other versions
BRPI0002872B8 (pt
BR0002872B1 (pt
Inventor
Jaime Dr Guardiola
Martin Dr Wolf
Original Assignee
Braun Melsungen Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Braun Melsungen Ag filed Critical Braun Melsungen Ag
Publication of BR0002872A publication Critical patent/BR0002872A/pt
Publication of BR0002872B1 publication Critical patent/BR0002872B1/pt
Publication of BRPI0002872B8 publication Critical patent/BRPI0002872B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Polymers & Plastics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

Patente de Invenção:<B>"SOLUçãO AQUOSA PARA NUTRIçãO PARENTERAL''<D>. A invenção refere-se a uma solução aquosa para nutrição parenteral de mamíferos consistindo em: a) um padrão de aminoácido calculado com base em 100 g/l de aminoácidos: Isoleucina 4,0 - 5,5 g/l Leucina 8,0 - 10,0 g/l Lisina 6,0 - 8,0 g/l Metionina 4,0 - 6,0 g/l Fenilalanina 4,0 - 6,0 g/l Treonina 4,0 - 6,0 g/l Triptofano 1,0 - 2,0 g/l Valina 6,0 - 8,0 g/l Arginina 10,0 - 12,0 g/l Histidina 1,5 - 3,5 g/l Alanina 9,0 - 12,0 g/l ácido Aminoacético 11,0 - 16,0 g/l (Glicina) Asparagina 0 - 1,0 g/l ácido aspártico 5,5 - 8,0 g/l Acetilcisteína 0 - 2,5 g/l ácido Glutâmico 6,0 - 10,0 g/l Ornitina 0 - 1,0 g/l Prolina 4,0 - 6,0 g/l Serina 1,0 - 3,0 g/l Tirosina* 0,1 - 0,5 g/l *como Acetiltirosina 0 - 2,0 g/l Taurina 0 - 4,0 g/l b) um padrão de eletrólitos de: Sódio 0 - 100,0 mmoles/l Potássio 0 - 80,0 mmoles/l Magnésio 0 - 8,0 mmoles/l Cálcio 0 - 8,0 mmoles/I e/ou Zinco 0 - 0,08 mmoles/l Fosfato 0 - 20,0 moles/l Cloreto 0 - 120,0 mmoles/l Acetato 0 - 120,0 mmoles/l ácido cítrico 0 - 10,0 mmoles/l Maleato 0 - 80,0 mmoles/l Lactato 0 - 10,0 mmoles/l Glicerofosfato 0 - 30,0 mmoles/l e/ou Gluconato 0 - 120,0 mmolesl e c) opcionalmente, uma solução de carboidrato (açúcar) e/ou emulsão de gordura.
BRPI0002872A 1999-06-26 2000-06-26 solução aquosa para nutrição parenteral. BRPI0002872B8 (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99112319A EP1062879B1 (en) 1999-06-26 1999-06-26 Aqueous solution for the parenteral nutrition

Publications (3)

Publication Number Publication Date
BR0002872A true BR0002872A (pt) 2001-01-30
BR0002872B1 BR0002872B1 (pt) 2013-02-19
BRPI0002872B8 BRPI0002872B8 (pt) 2021-05-25

Family

ID=8238438

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0002872A BRPI0002872B8 (pt) 1999-06-26 2000-06-26 solução aquosa para nutrição parenteral.

Country Status (12)

Country Link
US (1) US6337094B1 (pt)
EP (1) EP1062879B1 (pt)
CN (1) CN1172685C (pt)
BR (1) BRPI0002872B8 (pt)
CZ (1) CZ302247B6 (pt)
DE (1) DE69910746T2 (pt)
ES (1) ES2205646T3 (pt)
HU (1) HUP0002397A2 (pt)
PL (1) PL195782B1 (pt)
PT (1) PT1062879E (pt)
RU (1) RU2242990C2 (pt)
SK (1) SK284190B6 (pt)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69910746T2 (de) * 1999-06-26 2004-06-17 B. Braun Melsungen Ag Wässrige Lösung für parenterale Nahrung
US20030105104A1 (en) 2001-11-27 2003-06-05 Burzynski Stanislaw R. Formulation of amino acids and riboflavin useful to reduce toxic effects of cytotoxic chemotherapy
EP1327443A1 (en) * 2001-12-21 2003-07-16 Kyowa Hakko Kogyo Co., Ltd. Therapeutic or preventing agent for the diseases caused by a decrease in the expression level of the klotho protein
EP3184107A1 (en) * 2002-06-19 2017-06-28 N.V. Nutricia Method and preparation for treating metabolic stress
AU2003268342A1 (en) * 2002-08-30 2004-03-19 Novus International, Inc. Antimicrobial compositions
US6881750B2 (en) * 2003-03-04 2005-04-19 Nutrition Corp. Of America, Ltd. Potassium taurate bicarbonate and ascorbate
FR2851889B1 (fr) * 2003-03-06 2007-05-04 Larena Sa Produit destine a la restauration de la tolerance aux antigenes alimentaires et bacteriens, et composition dietetique ou alimentaire contenant un tel produit
US7465471B2 (en) 2003-03-21 2008-12-16 Novus International, Inc. Palatability of aquaculture feed
EP1806134B1 (en) * 2004-09-17 2012-07-11 Ajinomoto Co., Inc. Agent and food for preventing/improving functional digestive disorder
JP5188181B2 (ja) * 2005-08-25 2013-04-24 協和発酵バイオ株式会社 血中アルコール濃度上昇抑制用組成物
US20070286909A1 (en) * 2006-06-07 2007-12-13 Daniel S. Smith Amino acid compositions
WO2007147590A2 (en) * 2006-06-22 2007-12-27 Gambro, Inc. Solution and method to reduce, treat and/or prevent oxidative stress and cell activation
US8691843B2 (en) 2006-07-12 2014-04-08 Novus International, Inc. Antioxidant combinations for use in ruminant feed rations
EP2161986A4 (en) 2007-07-03 2014-06-25 Novus Int Inc FOOD RATIONS FOR PORCLES WITH LOW FERMENTABLE CARBOHYDRATE CONTENT
WO2009088879A1 (en) 2008-01-04 2009-07-16 Novus International Inc. Combinations to improve animal health and performance
DE102009012671A1 (de) * 2009-03-13 2010-09-16 B. Braun Melsungen Ag Plasmaadaptierte Vollelektrolytlösung
MX2010000660A (es) * 2009-12-11 2011-06-14 Abbott Lab Soluciones de rehidratacion oral que comprenden dextrosa.
WO2019118519A1 (en) * 2017-12-11 2019-06-20 Filtricine, Inc. Compositions, methods, kits and systems for cancer treatment and metabolic intervention therapy
JP7311086B2 (ja) 2019-08-21 2023-07-19 ブレイン ケミストリー ラブズ 金属及びｌ－セリンを含む組成物、並びにその使用
WO2024108133A1 (en) * 2022-11-18 2024-05-23 5-Hour International Corporation Private Limited Hydration management product

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987003806A1 (en) * 1985-12-18 1987-07-02 Veech Richard L Parenteral nutrition therapy with amino acids
DE3916903A1 (de) * 1989-05-24 1991-02-28 Leopold Pharma Gmbh Waessrige zusammensetzung fuer die parenterale ernaehrung
DK0671166T3 (da) * 1991-04-26 2005-01-03 Mitsubishi Pharma Corp Næringstilförende præparater
US5206269A (en) * 1992-03-20 1993-04-27 Clintec Nutrition Co. Highly concentrated amino acid solution
DE4316326C1 (de) * 1993-05-15 1994-06-09 Fresenius Ag Hochkalorische, niederosmolare Lösung zur totalen parenteralen Ernährung durch periphervenöse Applikation
US5719133A (en) * 1994-09-21 1998-02-17 Novartis Nutrition Ag Adolescent dietary composition
JP2990686B2 (ja) * 1994-11-17 1999-12-13 田辺製薬株式会社 水溶性ビタミンｂ類配合総合輸液
DE69910746T2 (de) * 1999-06-26 2004-06-17 B. Braun Melsungen Ag Wässrige Lösung für parenterale Nahrung

Also Published As

Publication number Publication date
CN1279068A (zh) 2001-01-10
BRPI0002872B8 (pt) 2021-05-25
SK9572000A3 (en) 2001-01-18
RU2242990C2 (ru) 2004-12-27
ES2205646T3 (es) 2004-05-01
HUP0002397A2 (hu) 2002-02-28
BR0002872B1 (pt) 2013-02-19
CN1172685C (zh) 2004-10-27
EP1062879B1 (en) 2003-08-27
PL195782B1 (pl) 2007-10-31
EP1062879A1 (en) 2000-12-27
DE69910746D1 (de) 2003-10-02
DE69910746T2 (de) 2004-06-17
CZ20002390A3 (cs) 2001-02-14
PL340991A1 (en) 2001-01-02
CZ302247B6 (cs) 2011-01-12
PT1062879E (pt) 2003-12-31
HU0002397D0 (en) 2000-08-28
SK284190B6 (sk) 2004-10-05
US6337094B1 (en) 2002-01-08

Similar Documents

Publication Publication Date Title
BR0002872A (pt) Solução aquosa para nutrição parenteral.
Grimble The significance of peptides in clinical nutrition
Buck et al. On the mechanism of enzyme action. LXXIII. Studies on trypsins from beef, sheep and pig pancreas
WO2007133642A8 (en) Sport drink containing amino acids and carbohydrates
ATE296545T1 (de) Zusatz für die wiederherstellung des wachstumhormonspiegels
DE69723812D1 (de) Aminosäurezusammensetzungen
Osawa et al. Absorption and metabolism of orally administered collagen hydrolysates evaluated by the vascularly perfused rat intestine and liver in situ
AU703484B2 (en) Peptides for tissue and cell culture media
ATE343332T1 (de) Zusammensetzung, welche aminosäuren und trehalose enthält
UA89616C2 (ru) Гидролизат казеина, способ его получения и применения
JPS56110617A (en) Nutrient composition for young child
KR860002268A (ko) 피장(避腸)영양액의 제조방법
CA2359606A1 (en) Cysteine/glycine rich peptides
Ito et al. Tyrosinase-cytalyzed conjugation of dopa with glutathione
KR950032165A (ko) 토코페롤 유도체
DE60230621D1 (de) Essbare bzw. trinkbare sowie medizinisch verwendbare, die körpertemperatur erhöhende aminosäurezusammensetzung
ES363614A1 (es) Un metodo de preparar una composicion alimenticia de sabor agrandable para consumo humano.
WO2002102360A3 (en) Compositions based on branched chain amino acids for improving the myocardial ventricular function in patients suffering from diabetes
DE59001192D1 (de) Waessrige zusammensetzung fuer die parenterale ernaehrung.
KAWAMOTO et al. Regulation of N‐Acetylglutamate Synthetase in Mouse Liver: Postprandial Changes in Sensitivity to Activaation by Arginine
BRPI0511434A (pt) purificação de n-(fosfonometil)glicina
Sokolovsky et al. Nonenzymatic cleavage of peptide bonds: The half-cystine residues in bovine pancreatic ribonuclease
AU9625498A (en) Organ specific nutrition
JPS647983B2 (pt)
RU94024392A (ru) Минерально-аминокислотный концентрат

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: ALTERADA DA INT.CL: A23L 9/08, A23L 1/304, A23L 1/305

Ipc: A61K 9/08 (2009.01), A23L 1/48 (2009.01)

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 19/02/2013, OBSERVADAS AS CONDICOES LEGAIS.

B15K Others concerning applications: alteration of classification

Ipc: A61K 45/06 (2006.01), A23L 33/16 (2016.01), A23L 3

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 26/06/2000 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B21A Patent or certificate of addition expired [chapter 21.1 patent gazette]

Free format text: PATENTE EXTINTA EM 26/06/2020